2. Analisis probabilistik Bidang efektivitas biaya. Setiap titik adalah satu simulasi probabilistik. Titik di bawah sumbu nol berarti intervensi menurunkan biaya.-10 -8 -5 -2 0 2 5 -0,10 0,00 0,10 0,20 0,30 Tambahan tahun hidup berkualitas per pasien (QALY) Tambahan biaya per pasien (juta rupiah) 1 kali PDB per kapita 3 kali PDB per kapita Simulasi probabilistik (500 sampel) Kasus dasarKurva penerimaan. Peluang intervensi hemat biaya pada berbagai ambang kesediaan membayar.0 20 40 60 80 100 0 50 100 150 200 250 Ambang kesediaan membayar (juta rupiah per QALY) Peluang hemat biaya (%) 75 juta 225 juta 99,5% 3. Analisis sensitivitas Analisis sensitivitas satu arah. Sepuluh parameter dengan pengaruh terbesar terhadap manfaat moneter bersih.-20 -10 0 10 20 interventions aspirin low dose monotherapy transition rate multipliers stable condition to post nonfatal event interventions aspirin low dose mon...interventions clopidogrel 75mg monotherapy transition rate multipliers stable condition to dead interventions clopidogrel 75mg mon...interventions aspirin low dose monotherapy transition rate multipliers stable condition to dead interventions aspirin low dose mon...interventions aspirin low dose monotherapy transition rate multipliers stable condition to post major event interventions aspirin low dose mon...interventions clopidogrel 75mg monotherapy transition rate multipliers stable condition to post nonfatal event interventions clopidogrel 75mg mon...interventions aspirin low dose monotherapy transition rate multipliers post nonfatal event to dead interventions aspirin low dose mon...interventions clopidogrel 75mg monotherapy transition rate multipliers post nonfatal event to dead interventions clopidogrel 75mg mon...interventions clopidogrel 75mg monotherapy transition rate multipliers stable condition to post major event interventions clopidogrel 75mg mon...interventions aspirin low dose monotherapy transition rate multipliers post nonfatal event to post major event interventions aspirin low dose mon...interventions clopidogrel 75mg monotherapy annual drug cost idr interventions clopidogrel 75mg mon...Perubahan manfaat moneter bersih per pasien (juta rupiah) Parameter Parameter pada nilai rendah Parameter pada nilai tinggi5. Validasi model Keseimbangan massa kohort terpenuhi pada seluruh siklus (simpangan terbesar 0,0000%).
6. Penyesuaian untuk Indonesia Uraian berikut tersedia dalam bahasa Inggris.
KMK 1199/2025 Fornas status was re-audited for this indication and formulation through the official decision page: https://farmalkes.kemkes.go.id/unduh/keputusan-menteri-kesehatan-republik-indonesia-nomor-hk-01-07-menkes-1199-2025-tentang-formularium-nasional/ The searchable e-Fornas catalogue was cross-checked at: https://e-fornas.farmalkes.kemkes.go.id/guest/landing Policy route: PRB maintenance optimization. Is clopidogrel monotherapy good value versus aspirin for stable secondary prevention, and which subgroups justify the added cost? CAPRIE reported a relative-risk reduction of 8.7% for the vascular composite versus aspirin in a broad secondary-prevention population: https://pubmed.ncbi.nlm.nih.gov/8918275/